Jyothy Labs Limited (NSE:JYOTHYLAB)
India · Delayed Price · Currency is INR 200.38
-2.31 (-1.14%)
Nov 11, 2026, 1:50 PM IST
Jyothy Labs Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 29,905 | 29,443 | 28,439 | 27,569 | 24,860 | 21,965 |
Other Revenue | - | - | - | - | - | 3.12 |
| 29,905 | 29,443 | 28,439 | 27,569 | 24,860 | 21,968 | |
Revenue Growth | 4.56% | 3.53% | 3.16% | 10.90% | 13.16% | 15.03% |
Cost of Revenue | 17,680 | 15,697 | 14,240 | 14,132 | 14,437 | 12,910 |
Gross Profit | 12,225 | 13,746 | 14,200 | 13,437 | 10,424 | 9,058 |
Selling, General & Admin | 5,651 | 5,719 | 5,682 | 5,313 | 4,412 | 4,111 |
Other Operating Expenses | 3,570 | 3,437 | 3,398 | 3,223 | 2,737 | 2,352 |
Operating Expenses | 9,867 | 9,769 | 9,663 | 9,036 | 7,650 | 7,045 |
Operating Income | 2,358 | 3,977 | 4,536 | 4,402 | 2,774 | 2,013 |
Interest Expense | -48.2 | -49.9 | -59.3 | -47.3 | -130.3 | -117.64 |
Interest & Investment Income | 187.5 | 187.5 | 218.7 | 230.1 | 76.5 | 38.76 |
Currency Exchange Gain (Loss) | 11.8 | 11.8 | 1.6 | 0.8 | 2.3 | 1.67 |
Other Non Operating Income (Expenses) | 9.7 | 41.1 | 25.3 | 22.3 | 18 | 19.49 |
EBT Excluding Unusual Items | 2,519 | 4,168 | 4,722 | 4,607 | 2,740 | 1,956 |
Gain (Loss) on Sale of Investments | 345.1 | 345.1 | 213 | 41.3 | - | - |
Gain (Loss) on Sale of Assets | -0.8 | -0.8 | -2.9 | 139.7 | 181.5 | 15.24 |
Asset Writedown | - | - | - | - | - | -1.69 |
Other Unusual Items | - | - | -37 | - | 70.3 | - |
Pretax Income | 2,863 | 4,512 | 4,896 | 4,788 | 2,992 | 1,969 |
Income Tax Expense | 794.5 | 1,180 | 1,184 | 1,095 | 594.9 | 377.91 |
Earnings From Continuing Operations | 2,069 | 3,332 | 3,712 | 3,693 | 2,397 | 1,591 |
Minority Interest in Earnings | - | - | - | 1.5 | - | 28.43 |
Net Income | 2,069 | 3,332 | 3,712 | 3,695 | 2,397 | 1,620 |
Net Income to Common | 2,069 | 3,332 | 3,712 | 3,695 | 2,397 | 1,620 |
Net Income Growth | -40.59% | -10.23% | 0.47% | 54.11% | 48.01% | -18.79% |
Shares Outstanding (Basic) | 367 | 367 | 367 | 367 | 367 | 367 |
Shares Outstanding (Diluted) | 367 | 367 | 367 | 367 | 367 | 367 |
Shares Change | -0.01% | 0.02% | 0.01% | 0.01% | - | - |
EPS (Basic) | 5.64 | 9.07 | 10.11 | 10.06 | 6.53 | 4.41 |
EPS (Diluted) | 5.64 | 9.07 | 10.11 | 10.06 | 6.53 | 4.41 |
EPS Growth | -40.59% | -10.27% | 0.48% | 54.10% | 48.04% | -18.79% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 1,505 | 3,453 | 2,534 | 4,208 | 2,932 | 1,765 |
Free Cash Flow Per Share | 4.10 | 9.40 | 6.90 | 11.46 | 7.98 | 4.81 |
Dividend Per Share | - | 3.500 | 3.500 | 3.500 | 3.000 | 2.500 |
Dividend Growth | - | 0% | 0% | 16.67% | 20.00% | -37.50% |
Gross Margin | 40.88% | 46.69% | 49.93% | 48.74% | 41.93% | 41.23% |
Operating Margin | 7.89% | 13.51% | 15.95% | 15.96% | 11.16% | 9.16% |
Profit Margin | 6.92% | 11.32% | 13.05% | 13.40% | 9.64% | 7.37% |
Free Cash Flow Margin | 5.03% | 11.73% | 8.91% | 15.26% | 11.79% | 8.04% |
EBITDA | 2,722 | 4,313 | 4,834 | 4,681 | 3,069 | 2,391 |
EBITDA Margin | 9.10% | 14.65% | 17.00% | 16.98% | 12.35% | 10.89% |
D&A For EBITDA | 363.3 | 335.5 | 298.3 | 279.1 | 295.2 | 378.06 |
EBIT | 2,358 | 3,977 | 4,536 | 4,402 | 2,774 | 2,013 |
EBIT Margin | 7.89% | 13.51% | 15.95% | 15.96% | 11.16% | 9.16% |
Effective Tax Rate | 27.75% | 26.15% | 24.18% | 22.88% | 19.88% | 19.19% |
Revenue as Reported | 30,549 | 30,119 | 28,994 | 28,107 | 25,256 | 22,152 |
Advertising Expenses | - | 2,275 | 2,397 | 2,282 | 1,743 | 1,611 |